Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with abiraterone in pre-docetaxel setting
Year: 2017
Type: article
Study design: Observational Study
Source: Annals of Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: metastatic castration-resistant prostate cancer, abiraterone, systemic inflammatory markers, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, progression-free survival, prognostic factors, treatment response monitoring, inflammation and cancer progression, bone metastasis, visceral metastases
Open Access status: bronze
OpenAlex ID: W2762977458
